Multiple Sclerosis Trial, Recruiting (NCT06728956)

Multiple Sclerosis Trial, Recruiting NCT06728956 Sponsor: The Leeds Teaching Hospitals NHS Trust Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06728956 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are able to give informed consent to participate in research
People aged 18 years or older
People who are currently in paid work and plan to stay in paid work for at least the next 6 months
For Phase 2: Registered healthcare professionals or allied health professionals who work directly with patients who have Multiple Sclerosis
For Phase 3: People who have been clinically diagnosed with Multiple Sclerosis and have scored 11 or more out of 22 on a work-related questionnaire called the MS-WIS (confirm with trial site)

Who may not be able to join:

People who are not able to give informed consent
People who plan to leave paid work within the next 6 months
People who will not have regular access to an internet-connected device, such as a laptop or smartphone, for the full duration of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06728956

Sponsor: The Leeds Teaching Hospitals NHS Trust

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

More information: https://clinicaltrials.gov/study/NCT06728956

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are able to give informed consent to participate in research
People aged 18 years or older
People who are currently in paid work and plan to stay in paid work for at least the next 6 months
For Phase 2: Registered healthcare professionals or allied health professionals who work directly with patients who have Multiple Sclerosis
For Phase 3: People who have been clinically diagnosed with Multiple Sclerosis and have scored 11 or more out of 22 on a work-related questionnaire called the MS-WIS (confirm with trial site)

Who may not be able to join:

People who are not able to give informed consent
People who plan to leave paid work within the next 6 months
People who will not have regular access to an internet-connected device, such as a laptop or smartphone, for the full duration of the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Leeds Teaching Hospitals NHS Trust

Registry

ClinicalTrials.gov

Start date

14 June 2024

Est. completion

1 July 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Multiple Sclerosis Work Instability Scale (MS-WIS); Psychological Flexibility -Multi-dimensional Psychological Flexibility Inventory (MPFI); Resilience Connor-Davidson Resilience Scale (CD-RISC 10); Self-efficacy -Unidimensional Self-efficacy scale for Multiple Sclerosis (USE-MS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov